OWC Pharmaceutical registers $2.37 million stock for secondary sale

Selling stockholders to sell 9,101,373 common shares through offering

By Devika Patel

Knoxville, Tenn., April 23 – OWC Pharmaceutical Research Corp. selling shareholders plan to sell 9,101,373 common shares in a secondary sale with a 30-day greenshoe of 661,765 additional shares, according to a Form S-1 filed Thursday with the Securities and Exchange Commission. The registration is for up to $2.37 million of stock.

The Petach Tikva, Israel, company is seeking to commercialize and market its Electromagnetic Percussion Device and develop cannabis-based medical products.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.